Advertisement

Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose

      Vitamin D has in vitro and in vivo effects on β cells and insulin sensitivity. Vitamin D deficiency (VDD) has been associated with the onset and progression of type 2 diabetes mellitus (DM-2). However, studies involving supplementation of vitamin D in subjects with previously established diabetes have demonstrated inconsistent effects on insulin sensitivity. The aim of this open-label study was to assess the effects of high-dose vitamin D3 supplementation on insulin sensitivity in subjects with VDD and impaired fasting glucose. We studied 8 subjects with VDD and prediabetes with the modified, frequently sampled intravenous glucose tolerance (mFSIGT) test before and after vitamin D supplementation. Vitamin D3 was administered as 10,000 IU daily for 4 weeks. The mFSIGT was analyzed with MinMod Millennium (purchased from Dr. Richard Bergman, Keck School of Medicine of USC, Los Angeles, Calif) to obtain estimates of acute insulin response to glucose (AIRg), insulin sensitivity (SI), and disposition index (DI). We found that AIRg decreased (P = 0.011) and SI increased (P = 0.012) after a intervention with vitamin D. If these findings are repeated in a randomized, double-blind study, the results indicate that orally administered high-dose vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose and suggests that high-dose vitamin D3 supplementation might provide an inexpensive public health measure in preventing, or at least delaying, the progression from impaired fasting glucose to diabetes.

      Abbreviations:

      AIRg (acute insulin response to glucose), BMI (body mass index), DI (disposition index), GCRC (General Clinical Research Center), mFSIGT (modified frequently sampled intravenous glucose tolerance test), SI (insulin sensitivity), VDD (vitamin D deficiency), vitamin D (cholecalciferol)
      To read this article in full you will need to make a payment

      References

        • Pittas A.G.
        • Lau J.
        • Hu F.B.
        • Dawson-Hughes B.
        The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis.
        J Clin Endocrinol Metab. 2007; 92: 2017-2029
        • Bourlon P.M.
        • Faure-Dussert A.
        • Billaudel B.
        The de novo synthesis of numerous proteins is decreased during vitamin D3 deficiency and is gradually restored by 1, 25-dihydroxyvitamin D3 repletion in the islets of langerhans of rats.
        J Endocrinol. 1999; 162: 101-109
        • Cade C.
        • Norman A.W.
        Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo.
        Endocrinology. 1986; 119: 84-90
        • Chertow B.S.
        • Sivitz W.I.
        • Baranetsky N.G.
        • et al.
        Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion.
        Endocrinology. 1983; 113: 1511-1518
        • Clark S.A.
        • Stumpf W.E.
        • Sar M.
        Effect of 1,25 dihydroxyvitamin D3 on insulin secretion.
        Diabetes. 1981; 30: 382-386
        • Gedik O.
        • Akalin S.
        Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man.
        Diabetologia. 1986; 29: 142-145
        • Kadowaki S.
        • Norman A.W.
        Dietary vitamin D is essential for normal insulin secretion from the perfused rat pancreas.
        J Clin Invest. 1984; 73: 759-766
        • Labriji-Mestaghanmi H.
        • Billaudel B.
        • Garnier P.E.
        • Malaisse W.J.
        • Sutter B.C.
        Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion.
        J Endocrinol Invest. 1988; 11: 577-584
        • Norman A.W.
        • Frankel J.B.
        • Heldt A.M.
        • Grodsky G.M.
        Vitamin D deficiency inhibits pancreatic secretion of insulin.
        Science. 1980; 209: 823-825
        • Nyomba B.L.
        • Bouillon R.
        • De Moor P.
        Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit.
        Endocrinology. 1984; 115: 191-197
        • Orwoll E.
        • Riddle M.
        • Prince M.
        Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus.
        Am J Clin Nutr. 1994; 59: 1083-1087
        • Borissova A.M.
        • Tankova T.
        • Kirilov G.
        • Dakovska L.
        • Kovacheva R.
        The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.
        Int J Clin Pract. 2003; 57: 258-261
        • Kumar S.
        • Davies M.
        • Zakaria Y.
        • et al.
        Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D.
        Postgrad Med J. 1994; 70: 440-443
        • Chiu K.C.
        • Chu A.
        • Go V.L.
        • Saad M.F.
        Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.
        Am J Clin Nutr. 2004; 79: 820-825
        • Boston R.C.
        • Stefanovski D.
        • Moate P.J.
        • et al.
        MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test.
        Diabetes Technol Ther. 2003; 5: 1003-1015
        • Vieth R.
        Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety.
        Am J Clin Nutr. 1999; 69: 842-856
        • Vieth R.
        The mechanisms of vitamin D toxicity.
        Bone Miner. 1990; 11: 267-272
        • Trang H.M.
        • Cole D.E.
        • Rubin L.A.
        • et al.
        Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.
        Am J Clin Nutr. 1998; 68: 854-858
        • Hathcock J.N.
        • Shao A.
        • Vieth R.
        • Heaney R.
        Risk assessment for vitamin D.
        Am J Clin Nutr. 2007; 85: 6-18
        • Rosen C.J.
        Clinical practice. Vitamin D insufficiency.
        N Engl J Med. 2011; 20: 248-254
        • Chang E.
        • Donkin S.S.
        • Teegarden D.
        Parathyroid hormone suppresses insulin signalling in differentiated adipocytes.
        FASEB J. 2008; 22: 881.3-
        • Fliser D.
        • Franek E.
        • Fode P.
        • et al.
        Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans.
        Nephrol Dial Transplant. 1997; 12: 933-938
        • Takiishi T.
        • Gysemans C.
        • Bouillon R.
        • Mathieu C.
        Vitamin D and diabetes.
        Endocrinol Metab Clin North Am. 2010; 39: 419-446
        • Alfonso B.
        • Liao E.
        • Busta A.
        • Poretsky L.
        Vitamin D in diabetes mellitus-a new field of knowledge poised for D-velopment.
        Diabetes Metab Res Rev. 2009; 25: 417-419